Sutro Biopharma, Inc.

STRO

STROSutro Biopharma, Inc. US flag

NASDAQ Global Market

27.18

USD

+2.75

- -

263.03MMarket Cap

Income Statement (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	60	52	38	43	43	62	68	154	62	102
+ Sales & Services Revenue	60	52	38	43	43	62	68	154	62	102
- Cost of Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Operating Income	-60	-52	-38	-43	-43	-62	-68	-154	-62	-102
- Operating Expenses	58	71	76	98	114	160	197	243	300	207
+ Selling, General & Admin	15	16	21	33	37	56	60	63	48	41
+ Research & Development	44	55	54	66	77	104	137	180	252	166
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	1	-19	-37	-55	-71	-99	-129	-89	-238	-105
- Non-Operating (Income) Loss	- -	- -	-2	- -	-39	7	-12	-1	-13	86
+ Interest Expense, Net	- -	- -	- -	- -	2	3	- -	9	-13	33
+ Interest Expense	- -	1	2	4	4	3	3	24	31	42
- Interest Income	- -	- -	2	4	2	1	3	15	44	9
+ Other Non-Op (Income) Loss	- -	- -	-2	- -	-41	4	-12	-10	- -	53
Pretax Income	2	-20	-35	-56	-32	-106	-117	-89	-225	-191
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	2	18	2	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	2	-20	-35	-56	-32	-106	-119	-107	-227	-191
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	2	-20	-35	-56	-32	-106	-119	-107	-227	-191
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	2	-20	-35	-56	-32	-106	-119	-107	-227	-191
- Preferred Dividends	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	- -	-20	-35	-56	-32	-106	-119	-107	-227	-191
EBIT	1	-19	-37	-55	-71	-99	-129	-89	-238	-105
EBITDA	7	-14	-33	-51	-67	-94	-123	-82	-231	-98
EBITDA Margin (%)	11.76	-27.6	-85.07	-118.61	-156.27	-151.39	-181.86	-53.64	-372.7	-95.26
EBITA	1	-19	-37	-55	-71	-99	-129	-89	-238	-105
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100
Operating Margin (%)	2.28	-37.25	-96.89	-129.79	-166.32	-159.22	-190.26	-58.07	-384.34	-102.41
Profit Margin (%)	2.85	-38.05	-91.93	-130.44	-75.2	-170.55	-175.89	-69.47	-366.62	-186.45
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	6	5	5	5	4	5	6	7	7	7
Basic Weighted Avg Shares	1	1	1	2	3	5	5	6	8	8
Basic EPS, GAAP	- -	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Basic EPS from Cont Ops	2.43	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Diluted Weighted Avg Shares	1	1	1	2	3	5	5	6	8	8
Diluted EPS, GAAP	- -	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Diluted EPS from Cont Ops	2.43	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49

Balance Sheet (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	50	26	210	129	378	219	353	422	343	151
+ Cash, Cash Equivalents & STI	48	22	204	118	368	198	334	376	317	141
+ Cash & Cash Equivalents	12	22	125	5	206	30	47	69	190	58
+ ST Investments	36	- -	79	113	162	168	287	306	127	83
+ Accounts & Notes Receiv	1	2	2	6	6	12	7	36	9	4
+ Accounts Receivable, Net	1	2	2	6	6	12	7	36	9	4
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	2	2	3	4	4	8	12	10	18	6
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	20	15	13	28	16	123	54	49	44	23
+ Property, Plant & Equip, Net	19	14	11	10	13	52	51	45	36	22
+ Property, Plant & Equip	39	39	40	43	50	85	89	87	84	49
- Accumulated Depreciation	20	25	29	34	37	33	38	42	49	27
+ LT Investments & Receivables	- -	- -	- -	16	- -	69	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	16	- -	69	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	1	1	2	3	3	3	3	4	8	1
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	1	1	2	3	3	3	3	4	8	1
Total Assets	69	41	223	156	394	341	407	471	387	174
+ Payables & Accruals	3	3	3	6	6	14	16	44	38	39
+ Accounts Payable	3	3	3	6	6	6	5	9	10	8
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	15	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	- -	- -	8	12	19	27	32
+ ST Debt	- -	15	5	1	- -	10	17	10	7	8
+ ST Borrowings	- -	15	5	1	- -	9	12	4	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	1	5	6	7	8
+ Other ST Liabilities	47	14	29	26	24	17	33	39	87	28
+ Deferred Revenue	44	11	22	19	15	5	17	21	70	11
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	3	4	7	7	9	11	16	19	17	18
Total Current Liabilities	50	32	36	33	30	42	67	94	132	75
+ LT Debt	- -	- -	10	9	25	47	33	23	16	8
+ LT Borrowings	- -	- -	10	9	25	16	4	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -	31	30	23	16	8
+ Other LT Liabilities	110	118	45	17	8	- -	90	204	195	223
+ Accrued Liabilities	6	14	45	17	7	- -	90	202	193	222
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	104	104	- -	- -	- -	- -	- -	2	2	2
Total Noncurrent Liabilities	110	118	55	26	32	47	123	227	211	231
Total Liabilities	160	150	92	59	62	89	190	321	343	306
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	5	6	282	293	560	586	670	709	831	845
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	5	6	282	293	560	586	670	709	831	845
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-95	-115	-150	-196	-228	-333	-453	-559	-787	-978
+ Other Equity	- -	- -	- -	- -	- -	- -	-1	- -	- -	- -
Equity Before Minority Interest	-91	-109	132	98	332	253	217	150	45	-132
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-91	-109	132	98	332	253	217	150	45	-132
Total Liabilities & Equity	69	41	223	156	394	341	407	471	387	174
Shares Outstanding	2	2	2	2	5	5	6	6	8	9
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	32	34	30	23	16
Net Debt	-12	-7	-111	5	-182	-5	-31	-65	-190	-58
Net Debt to Equity	12.75	6.84	-84.06	5.03	-54.69	-2.1	-14.27	-43.57	-426.68	43.89
Tangible Common Equity Ratio	-131.21	-267.36	58.95	62.54	84.25	73.98	53.34	31.79	11.52	-76.2
Current Ratio	0.99	0.8	5.76	3.9	12.78	5.24	5.31	4.5	2.6	2.01
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	2	-20	-35	-56	-32	-106	-119	-107	-227	-191
+ Depreciation & Amortization	6	5	5	5	4	5	6	7	7	7
+ Non-Cash Items	1	5	1	9	-28	37	13	23	20	57
+ Stock-Based Compensation	1	1	3	10	12	23	26	25	25	14
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	3	- -	- -	- -	- -	- -	- -	- -	2
+ Other Non-Cash Adj	- -	- -	-2	-1	-40	13	-14	-2	-5	41
+ Chg in Non-Cash Work Cap	-22	-27	43	-23	-11	-18	104	-34	9	-50
+ (Inc) Dec in Accts Receiv	- -	-1	-1	-4	1	-7	5	-29	27	5
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-2	-1	- -	-4	-4	- -	-12	19
+ Inc (Dec) in Accts Payable	1	- -	- -	2	-1	9	5	30	-7	1
+ Inc (Dec) in Other	-22	-25	45	-20	-11	-15	97	-36	- -	-75
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-13	-37	13	-65	-68	-82	4	-112	-192	-177
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-4	-3	-2	-3	-7	-15	-8	-4	-3	-2
+ Acq of Fixed Prod Assets	-4	-3	-2	-3	-7	-15	-8	-4	-3	-2
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	84	- -	251	- -	56	12	97	- -
+ Increase in Capital Stock	- -	- -	84	- -	251	- -	56	12	97	- -
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	14	36	-79	-48	8	-82	-27	- -	222	47
+ Dec in LT Investment	66	50	3	149	138	167	189	461	683	312
+ Inc in LT Investment	-52	-14	-81	-196	-131	-249	-217	-460	-462	-265
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	10	33	-80	-51	1	-97	-35	-4	219	45
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	15	- -	-5	15	- -	-9	-12	-4	- -
+ Cash From Debt	- -	15	- -	- -	25	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	-5	-10	- -	-9	-12	-4	- -
+ Other Financing Activities	- -	- -	86	1	3	3	1	138	2	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	15	171	-4	269	3	48	138	94	- -
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	-3	10	103	-120	202	-176	17	22	121	-132
EBITDA	7	-14	-33	-51	-67	-94	-123	-82	-231	-98
EBITDA Margin (%)	11.76	-27.6	-85.07	-118.61	-156.27	-151.39	-181.86	-53.64	-372.7	-95.26
Free Cash Flow	-18	-40	11	-69	-75	-97	-4	-116	-195	-179
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	-18	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-25	11	-74	-60	-97	-14	-128	-199	-179
Free Cash Flow per Basic Share	-25.08	-57.72	19.32	-29.84	-23	-21.03	-0.85	-19.27	-25.16	-21.06
Price/Free Cash Flow	- -	- -	3.65	-4.1	-11.66	-10.34	35.94	-2.41	-0.76	-0.56
Cash Flow to Net Income	-7.73	1.88	-0.36	1.17	2.11	0.77	-0.03	1.05	0.84	0.93
Capital Expenditures	-4	-3	-2	-3	-7	-15	-8	-4	-3	-2